| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Grace Therapeutics, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 40,000 | 14 Apr 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| GRCE | Grace Therapeutics, Inc. | 14 Apr 2025 | 1 | $0 | 4 | Chief Medical Officer | 16 Apr 2025, 20:58 |
| GRCE | Acasti Pharma Inc. | 06 May 2024 | 1 | $0 | 4 | Chief Medical Officer | 08 May 2024, 19:19 |
| GRCE | Acasti Pharma Inc. | 14 Jul 2023 | 1 | $0 | 4 | Chief Medical Officer | 18 Jul 2023, 16:34 |
| GRCE | Acasti Pharma Inc. | 08 May 2023 | 0 | $0 | 3 | Chief Medical Officer | 26 May 2023, 15:06 |